ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0779
0.00%
Brent Oil
72.72
0.00%
Bitcoin
98,028.06
0.27%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Alkido Pharma Inc (AIKI) Cotización

Alkido Pharma Inc

Alkido Pharma Inc (AIKI)

NASDAQ
3.56
0.00
(0.00%)
Cerrado 21 Diciembre 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
3.56
Postura de Compra
3.53
Postura de Venta
3.98
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
19.028M
Precio Anterior
3.56
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
5,345,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.38
Beneficio por acción (BPA)
-4.28
turnover
2.04M
Beneficio neto
-22.88M

Acerca de Alkido Pharma Inc

AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin... AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Mostrar más

Sector
Security Brokers & Dealers
Industria
Security Brokers & Dealers
Sitio web
www.dominariholdings.com
Sede
Wilmington, Delaware, USA
Fundado
-

AIKI Últimas noticias

Más noticias

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown" PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- Dominari Holdings Inc...

21 Junio 2023
PR Newswire (US)

Dominari Holdings Appoints George Way Chief Financial Officer

Dominari Holdings Appoints George Way Chief Financial Officer PR Newswire NEW YORK, April 3, 2023 Experienced Finance Executive to Support Growth Strategy  NEW YORK, April 3, 2023 /PRNewswire/...

03 Abril 2023
PR Newswire (US)

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Feb. 24, 2023 NEW YORK, Feb. 24, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

24 Febrero 2023
PR Newswire (US)

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec. 28, 2022 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

28 Diciembre 2022
PR Newswire (US)

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma...

22 Diciembre 2022
PR Newswire (US)

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire NEW YORK, Nov. 28, 2022 Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW...

28 Noviembre 2022
PR Newswire (US)

AIkido Share Repurchase Continues

AIkido Share Repurchase Continues PR Newswire NEW YORK, Oct. 6, 2022 NEW YORK, Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

06 Octubre 2022
PR Newswire (US)

AIkido Purchases More Shares

AIkido Purchases More Shares PR Newswire NEW YORK, Oct. 5, 2022 NEW YORK, Oct. 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on...

05 Octubre 2022
PR Newswire (US)

Share Repurchase Program Continues

Share Repurchase Program Continues PR Newswire NEW YORK, Oct. 4, 2022 NEW YORK, Oct. 4, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

04 Octubre 2022
PR Newswire (US)

AIkido Pharma Continues Share Repurchase Program

AIkido Pharma Continues Share Repurchase Program PR Newswire NEW YORK, Oct. 3, 2022 NEW YORK, Oct. 3, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today...

03 Octubre 2022
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

AIKI - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Alkido Pharma?
El precio actual de las acciones de Alkido Pharma es US$ 3.56
¿Cuántas acciones de Alkido Pharma están en circulación?
Alkido Pharma tiene 5,345,000 acciones en circulación
¿Cuál es la capitalización de mercado de Alkido Pharma?
La capitalización de mercado de Alkido Pharma es USD 19.03M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Alkido Pharma?
Alkido Pharma ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Alkido Pharma?
El ratio precio/beneficio de Alkido Pharma es -0.38
¿Cuál es el ratio de efectivo a ventas de Alkido Pharma?
El ratio de efectivo a ventas de Alkido Pharma es 4.27
¿Cuál es la moneda de reporte de Alkido Pharma?
Alkido Pharma presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Alkido Pharma?
El último ingresos anual de Alkido Pharma es USD 2.04M
¿Cuál es el último beneficio anual de Alkido Pharma?
El último beneficio anual de Alkido Pharma es USD -22.88M
¿Cuál es la dirección registrada de Alkido Pharma?
La dirección registrada de Alkido Pharma es 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Alkido Pharma?
La dirección del sitio web de Alkido Pharma es www.dominariholdings.com
¿En qué sector industrial opera Alkido Pharma?
Alkido Pharma opera en el sector SECURITY BROKERS & DEALERS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

AIKI Discussion

Ver más
Viewmont Viewmont 2 años hace
Got it thanks!
👍️0
Viewmont Viewmont 2 años hace
Hi, I haven't been following AIKI for a while, just noticed its not trading, checked TDA / google with no result, did the ticker change or not public anymore after company bought shares? Thanks!
👍️0
db101 db101 2 años hace
More insider shares purchased today…
👍️0
db101 db101 2 años hace
More insider shares purchased…
👍️0
db101 db101 2 años hace
AIKI looks to be headed back to 7…
👍️0
db101 db101 2 años hace
More insider shares purchased…
👍️0
db101 db101 2 años hace
A positive week… up 3.11%
👍️0
db101 db101 2 años hace
…more shares purchased by the CEO
👍️0
db101 db101 2 años hace
…AIKI seems to be getting its legs
👍️0
db101 db101 2 años hace
AIKI is undervalued…
👍️0
db101 db101 2 años hace
AIKI is ready…
👍️0
db101 db101 2 años hace
The Company reported that on October 5, 2022, the Company purchased 10,500 shares of common stock at $7.0679 per share.
👍️0
db101 db101 2 años hace
The Company reported that on October 4, 2022, the Company purchased 38,035 shares of common stock at $6.99 per share. Anthony Hayes, CEO of AIkido stated, "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding."
👍️0
db101 db101 2 años hace
AIKI is buying more shares… 45k
👍️0
ANTI-BAGHOLDER ANTI-BAGHOLDER 3 años hace
Shalom Auerbach board member on AMRR doesn’t mess around.



Shalom Auerbach, a significant stockholder of AIkido Pharma Inc. (NASDAQ: AIKI) beneficially owning approximately 3.4% of its common stock, today issued the following letter to members of the AIkido Pharma Inc. Board of Directors:

https://www.streetinsider.com/dr/news.php?id=20187179&gfv=1
👍️0
PStockPickz PStockPickz 3 años hace
https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-motors-ltd-301386841.html
👍️0
PStockPickz PStockPickz 3 años hace
Averaging in some .48s
👍️0
PStockPickz PStockPickz 3 años hace
Snagging some 50s
👍️0
RNsidersbuying RNsidersbuying 3 años hace
AIkido Pharma announces $3M share repurchase program

https://ih.advfn.com/stock-market/NASDAQ/alkido-pharma-AIKI/stock-news/87087386/aikido-pharma-announces-3m-share-repurchase-progr
👍️0
urge2surge urge2surge 3 años hace
Classic dog pile here. I'm out and won't be back.
👍️0
RNsidersbuying RNsidersbuying 3 años hace
AIKI .47 - So, outsiders have sold this company's stock down to less than .50-on-the-dollar and insiders aren't filing Form-4-Buys by the truckload? How can management EVER promote it's own stock again when they show no interest in less than .50-on-the-dollar?

And what would be management's risk be in buying here at less than .50-on-the-dollar? It goes down to .25-on-the-dollar...whoa-is-me
👍️0
urge2surge urge2surge 3 años hace
One of the worst companies I've invested in. Finally dumped it for big loss. I obviously played the fool again. Glta
👍️0
georgie18 georgie18 3 años hace
AIKI...72...:partying_face:
👍️0
db101 db101 3 años hace
Get ready for the buttered popcorn...
👍️0
georgie18 georgie18 3 años hace
AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the Upside on this Oversold Chart...

Psar flipped Bullish...Been accumulating under $1...

Chart https://schrts.co/exhPMSRA ...
👍️0
White Lightning White Lightning 3 años hace
Looks like good news AlKl

https://apple.news/AnumIdrGsR-CRYxMFTxj-5Q

This should go over a dollar soon here!!!!
👍️0
TheFinalCD TheFinalCD 3 años hace
AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI

https://twitter.com/ohheytommy/status/1448004249493798912
👍️0
georgie18 georgie18 3 años hace
AIKI...92...on the P/M Gappa...:partying_face:
👍️0
urge2surge urge2surge 3 años hace
Impressed with the CEO management taking investment stakes in pivotal companies, thereby adding significant value here. Great job IMO.
👍️0
TGOO TGOO 3 años hace
Interesting, low ss here...
👍️0
Sirpeter Sirpeter 3 años hace
Very volatile but looks ready
👍️0
sportd sportd 3 años hace
Added let’s see what this can do
👍️0
Sirpeter Sirpeter 3 años hace
Kaboom!
👍️0
Sirpeter Sirpeter 3 años hace
Bullish
👍️0
antman antman 3 años hace
Would be nice... it has been ages since they did the financing around $1.65 and it began to drop ever since
👍️0
db101 db101 3 años hace
AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching
👍️0
db101 db101 3 años hace
News...
👍️0
georgie18 georgie18 3 años hace
AIKI...86...Tue, July 27, 2021, 10:00 AM
AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients

NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125. This technology relates to the use of novel and proprietary central nervous system (CNS) homing peptides. This technology has been exclusively sublicensed to AIkido Pharma for use of psilocybin for the therapeutic treatment of neuroinflammatory disease in cancer patients.
👍️0
georgie18 georgie18 3 años hace
AIKI...97...Bounce off the .85 range on the Bullish Engulfing Reversal Candle to the Upside...

Psar flipped to a Bullish Buy Position...as the MACD Crossed to the positive side...

Chart...https://schrts.co/FqVVQIHY ...
👍️0
wesley_ wesley_ 3 años hace
$1.10 nice
👍️0
urge2surge urge2surge 4 años hace
No respect from the street on this company. Corporate..how about getting some dignity and respect by actually executing and aggressive communications to the investing arena? Grow a pair..
👍️0
urge2surge urge2surge 4 años hace
Yeah definitely under substantial book value here. Not just on cash, but potential pipeline, nols, licensing rev's. You buy the dips here and wait on a significant return.
👍️0
Chess Master Chess Master 4 años hace
BULLISH RESEARCH ARTICLE! Trading under cash and great upside on great results. https://insiderfinancial.com/akido-pharmas-aiki-clinical-trial-results-continues-to-validates-gileads-21-billion-purchase-of-immunomedics/181580/
👍️0
ClayTrader ClayTrader 4 años hace
* * $AIKI Video Chart 04-21-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
georgie18 georgie18 4 años hace
AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

The article can be accessed at:
https://www.thepharmaletter.com/article/further-vindication-for-novartis-in-radioligand-space
👍️0
georgie18 georgie18 4 años hace
AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients...

https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1857821
👍️0
georgie18 georgie18 4 años hace
AIKI...$1.17...Bidding the Lower Band to the 20ma to add to my Core Position...

Looking for the 2 Open Gaps to fill and a $2 Breakout..imo...we shall see....

Chart...https://schrts.co/BrjKBXYy ...
👍️0
georgie18 georgie18 4 años hace
AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1849940 ...:party:
👍️0
Taurus69 Taurus69 4 años hace
$aiki $1.17 ? 0.0 (0.00%)
Volume: 3,920,435 @03/26/21 7:41:58 PM EDT
👍️0
ClayTrader ClayTrader 4 años hace
* * $AIKI Video Chart 03-24-2021 * *

Link to Video - click here to watch the technical chart video

👍️0

Su Consulta Reciente

NASDAQ
AIKI
Alkido Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados